Literature DB >> 16944348

MRI findings in benign multiple sclerosis are variable.

Sean J Pittock, John H Noseworthy, Moses Rodriguez.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16944348     DOI： 10.1007/s00415-006-0276-y

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

1.  Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features.

Authors:  R A Koopmans; D K Li; E Grochowski; P J Cutler; D W Paty
Journal:  Ann Neurol       Date:  1989-01       Impact factor: 10.422

2.  A short test of mental status: description and preliminary results.

Authors:  E Kokmen; J M Naessens; K P Offord
Journal:  Mayo Clin Proc       Date:  1987-04       Impact factor: 7.616

3.  Brain and spinal cord MR in benign multiple sclerosis: a follow-up study.

Authors:  M Filippi; A Campi; V Martinelli; B Colombo; G Scotti; G Comi
Journal:  J Neurol Sci       Date:  1996-11       Impact factor: 3.181

4.  Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.

Authors:  A J Thompson; A G Kermode; D G MacManus; B E Kendall; D P Kingsley; I F Moseley; W I McDonald
Journal:  BMJ       Date:  1990-03-10

5.  Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study.

Authors:  M Filippi; G J Barker; M A Horsfield; P R Sacares; D G MacManus; A J Thompson; P S Tofts; W I McDonald; D H Miller
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

6.  The short test of mental status. Correlations with standardized psychometric testing.

Authors:  E Kokmen; G E Smith; R C Petersen; E Tangalos; R C Ivnik
Journal:  Arch Neurol       Date:  1991-07

7.  Change in MS-related disability in a population-based cohort: a 10-year follow-up study.

Authors:  S J Pittock; W T Mayr; R L McClelland; N W Jorgensen; S D Weigand; J H Noseworthy; B G Weinshenker; M Rodriguez
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

8.  A longitudinal study of abnormalities on MRI and disability from multiple sclerosis.

Authors:  Peter A Brex; Olga Ciccarelli; Jonathon I O'Riordan; Michael Sailer; Alan J Thompson; David H Miller
Journal:  N Engl J Med       Date:  2002-01-17       Impact factor: 91.245

9.  Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup?

Authors:  C A Davie; N C Silver; G J Barker; P S Tofts; A J Thompson; W I McDonald; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-12       Impact factor: 10.154
  9 in total
  3 in total

Review 1.  Pharmacological treatment of early multiple sclerosis.

Authors:  Olaf Stüve; Jeffrey L Bennett; Bernhard Hemmer; Heinz Wiendl; Michael K Racke; Amit Bar-Or; Wei Hu; Robert Zivadinov; Martin S Weber; Scott S Zamvil; Maria F Pacheco; Til Menge; Hans-Peter Hartung; Bernd C Kieseier; Elliot M Frohman
Journal:  Drugs       Date:  2008       Impact factor: 9.546

2.  Corpus callosum damage and cognitive dysfunction in benign MS.

Authors:  Sarlota Mesaros; Maria A Rocca; Gianna Riccitelli; Elisabetta Pagani; Marco Rovaris; Domenico Caputo; Angelo Ghezzi; Ruggero Capra; Antonio Bertolotto; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2009-08       Impact factor: 5.038

3.  Comparison of the effects of low dose interferon and high dose interferon on reduction of the number and size of plaques in patients with Multiple Sclerosis: A historical cohort.

Authors:  Payam Khomand; Ghobad Moradi; Behrooz Ahsan; Setareh Abtahi
Journal:  Iran J Neurol       Date:  2017-01-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.